Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins
- PMID: 20722598
- PMCID: PMC4407829
- DOI: 10.2217/fmb.10.91
Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins
Abstract
Over the past few decades, our understanding of the bacterial protein toxins that modulate G proteins has advanced tremendously through extensive biochemical and structural analyses. This article provides an updated survey of the various toxins that target G proteins, ending with a focus on recent mechanistic insights in our understanding of the deamidating toxin family. The dermonecrotic toxin from Pasteurella multocida (PMT) was recently added to the list of toxins that disrupt G-protein signal transduction through selective deamidation of their targets. The C3 deamidase domain of PMT has no sequence similarity to the deamidase domains of the dermonecrotic toxins from Escherichia coli (cytotoxic necrotizing factor [CNF]1-3), Yersinia (CNFY) and Bordetella (dermonecrotic toxin). The structure of PMT-C3 belongs to a family of transglutaminase-like proteins, with active site Cys-His-Asp catalytic triads distinct from E. coli CNF1.
Conflict of interest statement
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Figures
References
-
- Dautin N, Karimova G, Ladant D. Bordetella pertussis adenylate cyclase toxin: a versatile screening tool. Toxicon. 2002;40(10):1383–1387. - PubMed
-
- Fabbri A, Travaglione S, Falzano L, Fiorentini C. Bacterial protein toxins: current and potential clinical use. Curr. Med. Chem. 2008;15(11):1116–1125. - PubMed
-
-
Kostrzewa RM, Segura-Aguilar J. Botulinum neurotoxin: evolution from poison, to research tool - onto medicinal therapeutic and future pharmaceutical panacea. Neurotox Res. 2007;12(4):275–290. ▪ Reviews the potential biomedical applications of bacterial toxins.
-
-
- Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 2007;31(5):515–534. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous